BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22220587)

  • 1. Cathepsin K expression in basal cell carcinoma.
    Ishida M; Kojima F; Okabe H
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e128-30. PubMed ID: 22220587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B and D expression in squamous cell carcinoma.
    Kawada A; Hara K; Kominami E; Kobayashi T; Hiruma M; Ishibashi A
    Br J Dermatol; 1996 Dec; 135(6):905-10. PubMed ID: 8977710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
    Poswar FO; Fraga CA; Farias LC; Feltenberger JD; Cruz VP; Santos SH; Silveira CM; de Paula AM; Guimarães AL
    Pathol Res Pract; 2013 Nov; 209(11):705-9. PubMed ID: 24011615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
    Karagece Yalçin U; Seçkın S
    Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
    Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of L-type amino acid transporter 1 in various skin lesions.
    Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
    Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal expression of cathepsin K in squamous cell carcinoma.
    Yan X; Takahara M; Xie L; Oda Y; Nakahara T; Uchi H; Takeuchi S; Tu Y; Moroi Y; Furue M
    J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):362-5. PubMed ID: 20524946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ber-EP4 is a useful marker for follicular germinative cell differentiation of cutaneous epithelial neoplasms.
    Ansai S; Takayama R; Kimura T; Kawana S
    J Dermatol; 2012 Aug; 39(8):688-92. PubMed ID: 22300237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
    O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
    Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases.
    Nijsten T; Colpaert CG; Vermeulen PB; Harris AL; Van Marck E; Lambert J
    Br J Dermatol; 2004 Oct; 151(4):837-45. PubMed ID: 15491425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histology of melanoma and nonmelanoma skin cancer.
    Müller CS
    Adv Exp Med Biol; 2014; 810():141-59. PubMed ID: 25207364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of placental-type glutathione S-transferase (GST-pi) in human cutaneous carcinoma in situ, that is, actinic keratosis and Bowen's disease, compared with normal human skin.
    Shimizu K; Toriyama F; Zhang HM; Yoshida H
    Carcinogenesis; 1995 Oct; 16(10):2327-30. PubMed ID: 7586130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Iconography in operative dermatology].
    Ruppel R; Schmitt H
    Z Hautkr; 1980 Sep; 55(18):1187-90. PubMed ID: 7467646
    [No Abstract]   [Full Text] [Related]  

  • 16. [The prognostic molecular factors in precancerous lesions and nonmelanotic skin carcinoma].
    Mihailovici MS; Teleman S; Ungureanu C
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):494-501. PubMed ID: 14756051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical visualization of the signature of activated Hedgehog signaling pathway in cutaneous epithelial tumors.
    Tanese K; Emoto K; Kubota N; Fukuma M; Sakamoto M
    J Dermatol; 2018 Oct; 45(10):1181-1186. PubMed ID: 30035333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lesion dimensions following ablative fractional laser treatment in non-melanoma skin cancer and premalignant lesions.
    Togsverd-Bo K; Paasch U; Haak CS; Haedersdal M
    Lasers Med Sci; 2012 May; 27(3):675-9. PubMed ID: 21960122
    [No Abstract]   [Full Text] [Related]  

  • 20. [Skin squamous cell carcinoma and its precancerous conditions].
    Laukkanen A; Rummukainen J; Kivinen P; Lappalainen K
    Duodecim; 2006; 122(1):71-9. PubMed ID: 16509192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.